Dr. Sankalp Chaudhary- MBBS, MBA’s Post

View profile for Dr. Sankalp Chaudhary- MBBS, MBA, graphic

Associate Consultant || Health Insurance || Middle East

☆Being fat is cool? The internet sure seems to think so, but drug companies (and investors) continue to bet on people preferring to actually be in good health. ☆It’s only something like health that can make a nearly $500bn stock move nearly 15% in a day. ☆At the same time, European counterpart Novo Nordisk (a $325bn stock) boomed 17.24%. What are investors taking? ☆Well, they’re probably not taking it yet, but given the fact that Eli Lilly and Company and Novo got positive news on treatments for a disease that affects 13% of the global adult population: obesity. ☆That’s 1.04bn people, by the way. A decent amount of customers, I guess. ☆Eli Lilly’s weight loss drugs Mounjaro drove the firm to stellar results for the quarter, while Novo’s Wegovy showed immensely beneficial lab test data, reducing heart attacks and stroke by 20%. ☆While making people less fat long-term might suck $ out of the healthcare ecosystem, investors couldn’t have cared less yesterday. Short-term profits FTW once again. #business #marketing #management #strategy #finance

  • No alternative text description for this image
Abhijit Basak

VP - Corporate Strategy, Business Development, Commercial Excellence | ex EY Partner

1y

So we'll have a very fit world once these two go off patent!!!!! Set the clock...

To view or add a comment, sign in

Explore topics